spikevax (previously covid-19 vaccine moderna)
moderna biotech spain, s.l. - single-stranded, 5’-capped messenger rna (mrna) produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - cjepiva - spikevax is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 months of age and older. spikevax bivalent original/omicron ba. 1 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 years of age and older who have previously received at least a primary vaccination course against covid-19. spikevax bivalent original/omicron ba. 4-5 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 months of age and older. spikevax xbb. 5 is indicated for active immunisation to prevent covid 19 caused by sars-cov-2 in individuals 6 months of age and older. the use of this vaccine should be in accordance with official recommendations.
tetraxim ≥ 30 d'ag'u/0.5 ml+ ≥ 40 md'ag'u/0.5 ml+ 25 µg/0.5 ml+ 25 µg/0.5 ml+ 40 d'ag'u/0.5 ml+ 8 d'ag'u/0.5 ml+ 32 d'ag'u/0.5 m
amicus pharma d.o.o. - пропорциональному protiv difterije, pertusisa, poliomijelitisa, tetanusa - suspenzija za injekciju - ≥ 30 d'ag'u/0.5 ml+ ≥ 40 md'ag'u/0.5 ml+ 25 µg/0.5 ml+ 25 µg/0.5 ml+ 40 d'ag'u/0.5 ml+ 8 d'ag'u/0.5 ml+ 32 d'ag'u/0.5 ml - 0,5 ml (1 doza) suspenzije sadrži: ≥ 30 i.j. toksoida difterije, prečišćeni + ≥40 i.j. toksoida tetanusa, prečišćeni + 25 mcg antigena bordetella pertussis toksoid + 25 mcg antigena bordetella pertussis filamentozni hemaglutinin + 40 jedinica d antigena tip 1 poliomijelitis virus, inaktivisani + 8 jedinica d antigena tip 2 poliomijelitis virus, inaktivisani + 32 jedinice d antigena tip 3 poliomijelitis virus, inaktivisani
pentaxim ≥ 30 i.j./0.5 ml+ ≥ 40 i.j./0.5 ml+ ≥ 25 µg/0.5 ml+ 40 d'ag'u/0.5 ml+ 8 d'ag'u/0.5 ml+ 32 d'ag'u/0.5 ml+ 10 µg/0.5 ml p
amicus pharma d.o.o. - пропорциональному protiv difterije, hemofilus utjecaj b, pertusisa, poliomijelitisa, tetanusa - prašak i suspenzija za suspenziju za injekciju - ≥ 30 i.j./0.5 ml+ ≥ 40 i.j./0.5 ml+ ≥ 25 µg/0.5 ml+ 40 d'ag'u/0.5 ml+ 8 d'ag'u/0.5 ml+ 32 d'ag'u/0.5 ml+ 10 µg/0.5 ml - 0,5 ml (1 doza ) pripremljene suspenzije sadrži: ≥ 30 i.j. prečišćeni toksoid difterije; ≥40 i.j prečišćeni toksoid tetanusa; 25 mcg antigen bordetella pertussis toksoid; 25 mcg antigen bordetella pertussis filamentozni hemaglutinin; 40 jedinica d antigena tip 1 poliomijelitis virus, inaktivisani; 8 jedinica d antig tip 2 poliomijelitis virus, inaktivisani; 32 jedinica d antigena tip 3 poliomijelitis virus, inaktivisani; 10 mcg polisaharid haemophilus influenzae tip b, konjugovani
paracetamol amsal 500 mg/1 tableta tableta
amsal pharmaceuticals d.o.o. - paracetamol - tableta - 500 mg/1 tableta - 1 tableta sadrži: 500 mg paracetamola
damar 250 mg/1 tableta+ 25 mg/1 tableta tableta
zada pharmaceuticals d.o.o. - karbidopa, леводопы - tableta - 250 mg/1 tableta+ 25 mg/1 tableta - 1 tableta sadrži: 250 mg levodopa i 25 mg karbidopa
bonqat
orion corporation - pregabalin - antiepileptici - mačke - alleviation of acute anxiety and fear associated with transportation and veterinary visits.
quviviq
idorsia pharmaceuticals deutschland gmbh - daridorexant hydrochloride - poremećaji uvođenja i održavanja spavanja - psycholeptics - quviviq is indicated for the treatment of adult patients with insomnia characterised by symptoms present for at least 3 months and considerable impact on daytime functioning.
zeldox 20 mg/1 kapsula kapsula, tvrda
viatris bh d.o.o. - ziprazidon - kapsula, tvrda - 20 mg/1 kapsula - 1 kapsula, tvrda sadrži: 20 mg ziprasidona (u obliku ziprasidonhidrohlorida)
zeldox 40 mg/1 kapsula kapsula, tvrda
viatris bh d.o.o. - ziprazidon - kapsula, tvrda - 40 mg/1 kapsula - 1 kapsula, tvrda sadrži: 40 mg ziprasidona (u obliku ziprasidonhidrohlorida)
zeldox 60 mg/1 kapsula kapsula, tvrda
viatris bh d.o.o. - ziprazidon - kapsula, tvrda - 60 mg/1 kapsula - 1 kapsula, tvrda sadrži: 60 mg ziprasidona (u obliku ziprasidonhidrohlorida)